HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Permissible Preservatives Cited As No. 1 Industry Challenge Under EU Reg

This article was originally published in The Rose Sheet

Executive Summary

In a survey conducted by IQPC division Pharma IQ, 31% of cosmetics industry members identified “what preservatives you can use” as the biggest challenge facing their business since implementation of the European Union’s Cosmetics Regulation in July 2013. Others cited challenges related to animal-testing alternatives and the regulation’s definition of nanomaterials.

You may also be interested in...



Top Stories Of 2014: Consumer Trust Sought With Legislation Still Absent

“The Rose Sheet” offers an overview of the year in cosmetics, analyzing 2014’s biggest news and the publication’s most-read stories. Notable happenings in 2014 included FDA’s rejection of an industry proposal for updating cosmetics oversight in the U.S., which has left cosmetics firms working to bolster consumer trust in an environment marked by increasing class litigation and calls for ingredient bans.

Exiting PCPC Science Chief Reflects On Role In Trying Climate

The Personal Care Products Council’s Halyna Breslawec is retiring from her position as the trade group’s chief scientist. In an interview with “The Rose Sheet,” she discusses maintaining focus on sound science during a challenging time for the industry.

EU Ushers In New Cosmetics Regs; Experts Offer Perspective

The EU’s new cosmetics regulation focuses on ensuring product safety and brings blanket regulatory uniformity to member states. It also could give rise to conflicts of interest within the supply chain and other challenges, experts say.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS019138

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel